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Abstract: Reuterin is a broad-spectrum antimicrobial system produced by specific strains of
Lactobacillus reuteri during anaerobic metabolism of glycerol. Acrolein is the main component
responsible for its antimicrobial activity. Here, the sensitivity of Campylobacter jejuni (n = 51) and
Campylobacter coli (n = 20) isolates from chicken meat and human stool samples to reuterin was
investigated. The minimum inhibitory concentration (MIC) of C. jejuni and C. coli strains was measured
between 1.5 and 3.0 µM of acrolein, below the MIC of the sensitive indicator strain Escherichia coli K12
(16.5µM acrolein). The interaction of C. jejuni N16-1419 and the reuterin-producing L. reuteri PTA5_F13
was studied during 24 h co-cultures with or without glycerol. A high C. jejuni growth was observed in
cultures without glycerol. In contrast, C. jejuni growth decreased from 7.3 ± 0.1 log CFU/mL to below
detection limit (1 log CFU/mL) during co-cultures added with 28 mM glycerol. This bactericidal effect
could be attributed to in situ reuterin production. The low MIC observed and the high sensitivity
towards in situ produced reuterin suggests L. reuteri combined with glycerol, as a possible intervention
option to reduce Campylobacter in the food chain.
Keywords: Acrolein; reuterin; antimicrobial; Lactobacillus reuteri; Campylobacter
1. Introduction
Campylobacter spp., mainly C. jejuni and C. coli, are the most commonly reported foodborne
pathogens in the European Union, with 246,307 confirmed cases of human campylobacteriosis in
2016 [1]. Related economic costs are estimated to be around 2.4 billion € in the EU per year [2]. Most
Campylobacter infections occur as sporadic cases rather than as outbreaks [3]. Several epidemiological
studies indicated that improper handling of raw meat from chickens that carry a high load of
Campylobacter is the major source of human infections [4].
Campylobacter infections in humans are usually self-limiting and do not require antibiotic therapy [5].
However, in severe cases, antibiotics such as ciprofloxacin, tetracycline and erythromycin can be
prescribed [6]. However, the efficiency of antibiotics against Campylobacter infections is decreasing due
to an increase in antibiotic resistance [7]. The use of antibiotics in poultry production may contribute
to the emergence of resistant strains in human through the food chain [8]. Nowadays, there is an
increasing interest in intervention strategies to reduce the presence of Campylobacter spp. in the poultry
meat production chain to lower the risk of Campylobacter exposure.
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Reuterin is a potent antimicrobial system produced by certain strains of Lactobacillus reuteri from
glycerol in a single reaction catalysed by the enzyme glycerol/diol dehydratase PduCDE [9]. Reuterin is
a dynamic multi-compound system consisting of 3-hydroxypropionaldehyde (3-HPA), 3-HPA hydrate,
3-HPA dimer and acrolein [10]. 3-HPA can be further metabolised to 1,3-propanediol (1,3-PDO) and
3-hydroxypropionate (3-HP) by the enzymes encoded by the propanediol-utilisation (pdu) operon
(Figure 1). Several studies found that reuterin solutions exhibit antimicrobial activities against a broad
range of Gram-positive and Gram-negative bacteria, yeasts, moulds, and protozoa [11]. This activity
has been attributed to reuterin causing depletion of free thiol groups in glutathione (GSH), proteins, and
enzymes, resulting in an imbalance of the cellular redox status which leads to bacterial cell death [12].













































Figure 1. Glycerol metabolism by reuterin-producing L. reuteri. Anaerobic metabolism of glycerol by
reuterin producing L. reuteri to 3-hydroxypropionaldehyde (3-HPA) and further to 3-hydroxypropionate
(3-HP) and 1,3-propanediol (1,3-PDO). In an aqueous environment, 3-HPA is quickly dimerised and
hydrated to form HPA-dimer and HPA-hydrate and also spontaneously dehydrates to acrolein.
PduQ, 1,3-PDO dehydrogenase; PduP, CoA-dependent propionaldehyde dehydrogenase; PduL,
phosphotransacetylase; PduW, propionate kinase.
L. reuteri is known to form stable biofilms in the crop and to persist in poultry gastrointestinal
(GI) tracts [14]. In the poultry industry, glycerol is used as energy feedstuff [15] and to improve feed
pellet quality [16]. Therefore, in situ reuterin production may be used as an active natural mechanism in
chicken colonised with reuterin-producing L. reuteri, to inhibit enteropathogens such as Campylobacter
in the gastrointestinal tract (GIT). However, to our knowledge, there is limited information on the
sensitivity of Campylobacter spp. to this broad-spectrum antimicrobial system. In this study, we assessed
the potential of reuterin to inhibit Campylobacter spp. The antimicrobial efficacy of reuterin was evaluated
on a panel of C. jejuni and C. coli isolated from various sources, including human stools, chicken GIT
and meat. The bactericidal activity of in situ-produced reuterin on C. jejuni was tested in co-cultures
with reuterin-producing L. reuteri, in the presence and absence of glycerol.
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2. Materials and Methods
2.1. Bacterial Strains, Media and Growth Conditions
Seventy-one (71) Campylobacter spp. (C. jejuni (n = 51) and C. coli (n = 20)) isolated from the chicken
intestine (n = 2), human stool samples (n = 50) and chicken meat (n = 19) in 2016 and 2017 with different
antibiotic resistance profiles were supplied by the National Centre for Enteropathogenic Bacteria
and Listeria (NENT; University of Zurich, Zurich, Switzerland) (Table S1). Before use, Campylobacter
strains were sub-cultured twice at 41 ◦C for 48 h on Blood Agar, 5% sheep blood (Oxoid AG, Pratteln,
Switzerland) under microaerobic conditions (5% O2, 10% CO2, 85% N2) generated using gas package
(Campygen, Oxoid AG, Pratteln, Switzerland). Cation adjusted Mueller Hinton broth (CAMHB)
(Becton Dickinson AG, Allschwil, Switzerland) was used for routine cultivation of C. jejuni and
C. coli. Quantification of C. jejuni was performed using CampyFood ID Agar (BioMérieux, Geneva,
Switzerland).
L. reuteri DSM20016 was obtained from the DSM strain collection (Leibniz Institute DSMZ-German
Collection of Microorganisms and Cell Cultures, Braunschweig, Germany). L. reuteri PTA8_11
(non-reuterin producer) and L. reuteri PTA5_F13, PTA6_C2 and PTA4_C2 (all three reuterin-producers)
were isolated from poultry gut and shown to share average nucleotide identity (ANI) of 95% with
reference strain L. reuteri DSM20016T [17]. They were obtained from our culture collection (Laboratory
of Food Biotechnology, ETH-Zürich, Switzerland). The reuterin producer chicken strains share
sequence similarity (98%) with the non-reuterin producer strain, while the latter lacks the glycerol/diol
dehydratase PduCDE (EC 4.2.1.30) required for reuterin synthesis [9]. These strains phylogenetically
cluster together in the poultry/human VI clade of L. reuteri, previously described [18]. Details on
the isolation, characterisation and efficiency of reuterin production of these strains were reported by
Greppi et al. [17].
L. reuteri strains were routinely cultivated in Man, Rogosa and Sharpe medium (MRS, Biolife,
Milan, Italy) at 37 ◦C under anaerobic condition supplied by gas package (AnaeroGen, Thermo Fisher
Diagnostics AG, Pratteln, Switzerland). The reuterin activity indicator strain E. coli K12 (ER2925) (New
England Biolabs, Ipswich, MA, USA) was cultured in brain heart infusion medium (BHI, Biolife, Milan,
Italy), at 37 ◦C. All bacterial strains were sub-cultured three times in liquid suspension for 14 h at 37 ◦C
before use.
2.2. Reuterin Production
L. reuteri PTA5_F13 was used for reuterin production with a two-step process using 600 mM glycerol,
as previously described [13]. Briefly, cell pellets obtained from exponentially grown L. reuteri PTA5_F13
were suspended in 600 mM glycerol solution and incubated at 25 ◦C for 2 h. The concentrations of
3-HPA and acrolein of the reuterin solution (supernatant) were measured by high-performance liquid
chromatography with refractive index detector (HLPC-RI) and ion-exclusion chromatography with
pulsed-amperometric detection (IC-PAD) analysis.
2.3. Reuterin Antimicrobial Activity Against a Panel of C. jejuni and C. coli Strains
The minimal inhibitory concentrations (MIC) and the minimal bactericidal concentrations (MBC)
of reuterin were determined using a broth microdilution assay, as previously described [19] with
some modifications. For antimicrobial activity testing, a fresh working solution of reuterin containing
1.4 mM acrolein was prepared in CAMH broth. Briefly, inocula were prepared from overnight grown
C. jejuni and C. coli on blood agar plates by resuspending colonies in sterile saline to obtain a turbidity
equivalent to 0.5 McFarland standard, corresponding to 5 × 105 colony forming units (CFU) per mL [20].
A hundred microliters of the working reuterin solution was added in the first row of a 96-well microtiter
plate (tissue culture plate with a flat bottom, Bioswisstec AG, Schaffhausen, Switzerland). In each of
the remaining wells, 50 µL CAMHB was added. Then a serial two-fold dilution was done by pipetting
50 µL from column 1 to 11. Reuterin was not added to the last well of a column which was used as
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positive growth control. Each well was then inoculated with the 0.5 McFarland-standardized bacterial
suspension. L. reuteri strains and E. coli K12 cells were tested in parallel and used as indicator organisms
for low and high sensitivity control of reuterin, respectively [21]. Both cultures were prepared in
their respective medium, and the inoculum was adjusted to 0.5 McFarland standard, as presented
above. The microtiter plates were incubated at 41 ◦C under microaerophilic and static conditions
for 24 h. The OD600 was measured using a PowerWave XS microplate spectrophotometer (BioTek,
Sursee, Switzerland). The MIC was defined as the first (lowest) dilution showing growth-inhibition
(OD600 < 0.1). The MBC was determined by spotting 10 µL of the dilution well corresponding to MIC,
as well as two-fold dilutions on CampyFood ID Agar. Agar plates were incubated in microaerophilic
conditions for 48 h in jars. The MBC was defined as the lowest dilution at which no growth on the
agar plate was observed. The MIC and MBC of reuterin against Campylobacter were expressed in µM
acrolein, since acrolein has been shown to be the main active component of the reuterin system [10,13].
Each strain was tested three times independently, and the results expressed as ranges of MIC or MBC
in µM of acrolein.
2.4. Glycerol Metabolism by Mono-Culture Assay of L. reuteri and C. jejuni under Microaerophilic
Growth Condition
Glycerol is the main substrate required for reuterin synthesis by L. reuteri. We tested the
ability of non-reuterin producing (L. reuteri PTA8_1) and reuterin-producing (L. reuteri PTA5_F13) to
synthesise reuterin from glycerol under the microaerophilic conditions required for optimal growth
of Campylobacter spp. We also measured the effect of glycerol supplementation on the growth and
metabolism of a reuterin-sensitive strain, C. jejuni N16-1419.
L. reuteri PTA8_1 and L. reuteri 5_F13 were grown overnight (16 h) in MRS broth at 37 ◦C. C. jejuni
N16-1419 was incubated for 24 h in CAMH broth at 41 ◦C under microaerobic conditions. Cells were
harvested at 3000× g for 2 min, washed once with phosphate buffer saline (PBS) and resuspended
with PBS to an OD600 of 6.0 (5.0 × 109 CFU/mL) for L. reuteri and 7.0 (1.0 × 1010 CFU/mL) for C. jejuni.
The cultures (300 µL) were inoculated at 1% (v/v) into 30 mL of CAMH broth containing 28 mM
glycerol. The inoculated medium was dispensed on 30 mL CAMH agar containing 28 mM glycerol in
75-cm2 tissue culture flasks with vented cap (Sigma-Aldrich, Buchs, Switzerland), forming a bi-phasic
medium previously recommended for optimal growth of Campylobacter spp. [22]. Inoculated bi-phasic
CAMH broth and agar without glycerol were used as control. Flasks were then incubated horizontally
at 41 ◦C, under microaerophilic conditions for 24 h. Cell growth was quantified by OD600, qPCR and
plate count after 24 h incubation. Metabolite production was measured in the culture supernatant
using HPLC-IR and IC-PAD. For viable cell counts determination, a ten-fold dilution series of 100 µL
samples of each culture were plated on CampyFood ID agar and MRS agar for the enumeration of
C. jejuni and L. reuteri, respectively. Plates for C. jejuni quantification were incubated in jars under
microaerophilic conditions generated by gas package (CampyGen, Thermo Fisher Diagnostics AG,
Pratteln, Switzerland) at 41 ◦C for 24 h. Plates for L. reuteri were incubated under anaerobic condition
supplied by gas package (AnaeroGen, Thermo Fisher Diagnostics AG, Pratteln, Switzerland) overnight
for 37 ◦C. Three independent replicates were performed.
2.5. Co-Culture Assays of L. reuteri and C. jejuni with Glycerol
Based on the results derived from microaerophilic growth of L. reuteri PTA8_1 and PTA5_F13 and
C. jejuni 16-1419 in CAMH broth with or without glycerol, we designed a co-culture assay to assess the
effect of in situ production of reuterin by L. reuteri on the survival and growth of C. jejuni.
For co-culture experiments, an inoculum of L. reuteri PTA8_1 or PTA5_F13 cultures prepared as
described above were co-inoculated with C. jejuni N16-1419 (all at 1%) in CAMH broth (30 mL) containing
28 mM glycerol. The incubation of the co-cultures were similar as described for mono-cultures.
The abundance of C. jejuni N16-1419 in co-culture was determined after 24 h incubation using viable
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plate counts on selective media (CampyFood ID Agar) and 16S rRNA gene quantitative PCR. The pH
and metabolites were measured. Three independent replicates were performed.
2.6. DNA Isolation and Quantitative PCR (qPCR) Analysis
Total genomic DNA was extracted from 2 mL samples of the mono-cultures and co-cultures
using the Fast DNA SPIN kit for soil (MP Biomedicals, Illkirch, France), following manufacturer’s
instructions. The DNA concentration and quality were assessed by absorbance measurements at
260 nm on a NanoDropVRND-1000 Spectro-photometer (Witec AG, Littau, Switzerland), and samples
were stored at −20 ◦C prior to the qPCR analyses.
To amplify and quantify the 16S rRNA gene copies, the primers specific for the 16S rRNA gene
for Lactobacillus (FWD: 5′-AGC AGT AGG GAA TCT TCC A-3′, REV: 5′-CGC CAC TGG TGY TCC
ATA TA-3′) [23] and Campylobacter (FWD: 5′-CTG CTT AAC ACA AGT TGA GTA GG-3′, REV: 5′-TTC
CTT AGG TAC CGT CAG AA-3′) [24] were used. Total DNA (1 µL) was used for amplification in
duplicate in 20 µL total reaction solution, containing 10 µL of SensiFAST SYBR No-ROX Kit (Bioline,
Luckenwalde, Germany) and 10 pmol of each primer. qPCR reactions were performed using a Roche
LightCycler 480 II, (Roche Diagnostics AG, Rotkreuz, Switzerland) in multiwell plate 96 at 95 ◦C for
3 min, followed by 45 cycles at 95 ◦C for 5 s, 60 ◦C for 30 s. At the end of the qPCR cycles, melting curve
analysis was performed to validate the specific generation of the expected PCR products. Each reaction
was run in duplicate. For quantification, a dilution series of standard obtained by amplification of the
linearised plasmid containing the representative gene of the target bacterial species was included in
each run. qPCR data were analysed using the LightCycler® 480 Software 1.5.1 (Roche Diagnostics AG,
Rotkreuz, Switzerland). PCR efficiency (%) was calculated from the slope of the standard curve for
each qPCR assay. Assay with an efficiency of 80–110% (slope 3.2–3.9) were retained. The number of
16S rRNA gene copies measured were corrected for multiple copies to estimate the number of C. jejuni
(2.1 mean gene copies) and L. reuteri (6.0 mean gene copies) cells using rrnDB version 5.5 [25].
2.7. Chemical Analyses
Glycerol, 1,3-PDO, 3-HPA, and microbial fermentation metabolites such succinate, acetate,
propionate and butyrate concentrations were determined by HPLC with refractive index detector
(HPLC-RI, Hitachi LaChrome, Merck, Dietikon, Switzerland) on an Aminex HPX-87H column (300 ×
7.8 mm, Bio-Rad, Reinach, Switzerland), as previously described [13]. Purification of 3-HPA used as
a standard was carried out as previously described [26].
Acrolein and 3-HP concentration were determined using ion-exclusion chromatography with
pulsed amperometric detection (IC-PAD) [10]. Commercial pure acrolein (>99%, stabilised with 0.2%
hydroquinone) from Sigma-Aldrich GmbH (Buchs, Switzerland) was used as an external standard.
Due to the overlapping of glycerol and lactate peaks in HPLC-RI chromatograms, total lactate in
the culture samples was enzymatically measured using D-/L-lactate (Rapid) Assay Kit (Megazyme,
Wicklow, Ireland), according to the manufacturers’ instruction.
2.8. Statistical Analysis
Data are mean values with a standard deviation of biological replicates. Statistical comparison of
metabolite productions, viable cell counts and qPCR data of mono-cultures and co-cultures with or
without 28 mM glycerol was evaluated by Students t-test using IBM SPSS 24.0 (IBM SPSS Statistics for
Windows, NY, USA). Significance was set at P-value of less than 0.05 (two-tailed).
3. Results
3.1. C. jejuni and C. coli Strains are Highly Sensitive to Reuterin Compared to E. coli K12 Indicator
The antimicrobial activity of reuterin expressed in acrolein concentration was tested against a panel
of 71 strains of C. jejuni and C. coli isolated from human stools (50) and chicken GIT (19) and meat (2).
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The reuterin stock solution was produced using L. reuteri PTA5_F13 and contained 402.9 mM 3-HPA,
51.2 mM 1.3-PDO and 8.5 mM acrolein from 600 mM glycerol. All tested Campylobacter strains exhibited
similar high sensitivity to reuterin with very low MIC and MBC in the range of 1.5 to 5.8 µM, which
were approximately ten folds lower than for E. coli K12 (Table 1). As expected, reuterin-producing
L. reuteri isolated from chicken showed lower sensitivity to reuterin, with MIC and MBC approximately
tenfold and hundredfold higher than E. coli K12 and Campylobacter strains, respectively.
Table 1. Activity of reuterin against a panel of Campylobacter spp., expressed in acrolein concentration.
A list of tested strains is presented in Table S1.
Organism Number of Strains MIC a (µM) MBC a (µM)
Campylobacter jejuni 51 1.5–3.0 3.0–5.8
Campylobacter coli 20 1.5–3.0 1.5–5.8
Campylobacter jejuni ATCC 33560 1 3.0 5.8
Lactobacillus reuteri 5 150.0 450.3
Escherichia coli K12 1 16.5 50.1
a Minimum inhibitory concentration (MIC) and minimal bactericidal concentrations (MBC) data are calculated from
three independent repetitions for each species.
3.2. L. reuteri PTA5_F13 Produces Reuterin under Microaerophilic Growth Conditions
Prior to co-culture trials, the production of reuterin of the selected strain, L. reuteri PTA5_F13, was
tested in the microaerophilic conditions used for Campylobacter growth, and the effect of glycerol was
as tested during Campylobacter mono-cultures.
There was no significant difference (p > 0.05) in abundance (colony counts and 16S rRNA gene
copies) and metabolic activity of C. jejuni N16-1419 in bi-phasic CAMH medium with or without
28 mM glycerol after 24 h incubation (Tables 2 and 3). C. jejuni N16-1419 viable cell counts reached
8 log CFU/mL, and succinate (6 mM) and acetate (4 mM) were the main metabolites produced. However,
the pH remained similar to the initial pH of the well-buffered CAMH medium (Table 2).
The non-reuterin producing L. reuteri PTA8_1 did not grow under the microaerophilic condition.
Glycerol was not consumed, and there was no significant difference (p > 0.05) in abundance and
metabolite concentrations after 24 h incubation in bi-phasic CAMH medium with or without 28 mM
glycerol (Tables 2 and 3). In these conditions, L. reuteri PTA8_1 produced acetate and lactate, and the
pH decreased from 7.3 for the non-inoculated CAMH medium to 6.8 after 24 h incubation (Table 2).
Similar to non-reuterin producing L. reuteri PTA8_1, we did not observe growth of the
reuterin-producing L. reuteri PTA5_F13 after 24 h incubation in CAMH medium under microaerophilic
condition for 24 h. However, L. reuteri PTA5_F13 converted approximately 13 mM (54%) glycerol to
produce 0.2± 0.0 mM acrolein, 5.3± 0.3 mM 1,3-PDO, and 4.4± 0.3 3-HP (Table 2). Besides, significantly
(p < 0.05) higher levels of acetate and lactate were produced in the presence of glycerol compared to
without. A significantly lower (p < 0.05) viable cell counts was measured after 24 h incubation with
glycerol (4.5 ± 0.4 CFU/mL) compare to without glycerol (6.7 ± 0.1 CFU/mL). However, no difference (p
> 0.05) was observed for the 16S rRNA gene abundance (Table 3). Collectively, our data indicate that the
reuterin-producing L. reuteri PTA5_F13 was not able to grow in the conditions used for Campylobacter
growth, but was metabolically active and produced reuterin under microaerophilic culture conditions.
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Table 2. Glycerol utilisation and metabolite formation of single strain cultures and co-cultures after 24 h incubation with or without glycerol. pH, glycerol, reuterin
and metabolite concentrations of single strain and co-cultures with and without glycerol.
Strains Treatment pH 1















C. jejuni N16-1419 Glycerol 7.2 ± 0.1
A 0.0 <0.1 A 4.4 ± 0.5 A 5.3 ± 0.4 A ND ND ND
No glycerol 7.3 ± 0.1 A - <0.1 A 4.0 ± 0.3 A 6.2 ± 0.6 A ND ND ND
L. reuteri PTA8-1
Glycerol 6.8 ± 0.1 A 0.0 0.2 ± 0.1 A 1.9 ± 0.1 A ND ND ND ND
No glycerol 6.8 ± 0.1 A - 0.3 ± 0.1 A 2.0 ± 0.1 A ND ND ND ND
L. reuteri PTA5-F13
Glycerol 6.1 ± 0.1 A 12.9 ± 1.1 0.7 ± 0.1 A 3.0 ± 0.1 A ND 0.2 ± 0.0 5.3 ± 0.3 4.4 ± 0.3
No glycerol 6.8 ± 0.1 B - 0.2 ± 0.1 B 1.9 ± 0.1 B ND ND ND ND
C. jejuni N16-1419 + L. reuteri PTA8-1 Glycerol 7.2 ± 0.1
A 0.0 <0.1 A 6.8 ± 0.1 A 5.4 ± 0.6 A ND ND ND
No glycerol 7.3 ± 0.1 A - <0.1 A 6.7 ± 0.4 A 5.9 ± 0.8 A ND ND ND
C. jejuni N16-1419 + L. reuteri PTA5-F13 Glycerol 5.8 ± 0.1
A 25.4 ± 0.4 2.2 ± 0.1A 3.4 ± 0.1 A 0.8 ± 0.1 A 0.1 ± 0.0 6.2 ± 0.6 4.9 ± 0.8
No glycerol 7.3 ± 0.1 B - <0.1 B 7.9 ± 0.5 B 5.7 ± 1.3 B ND ND ND
Data presented as the mean and standard deviation of three biological replicates. Mean values with different alphabetical superscript letters are significantly different at p < 0.05. ND; not
detected with detection limits: 1.0 mM for glycerol, 0.4 mM for succinate, 0.3 mM for 1,3-PDO, 4.4 µM for acrolein and 1.5 mM for 3-HP. 1 The pH of the original Cation adjusted Mueller
Hinton broth (CAMHB) was 7.3. 2 Initial glycerol concentration was 28 mM.
Table 3. Viable cell counts and 16S rRNA gene copy number of mono-cultures and co-cultures after 24 h culture in cation adjusted Mueller Hinton (CAMH) medium















C. jejuni N16-1419 8.1 ± 0.4 A 8.4 ± 0.6 A 9.6 ± 0.3 a 9.8 ± 0.1 a
L. reuteri PTA8_1 7.0 ± 0.2 a 6.6 ± 0.1 a 7.9 ± 0.1 A 7.3 ± 0.4 A
L. reuteri PTA5_F13 4.5 ± 0.4 A 6.7 ± 0.1 B 8.0 ± 0.2 a 7.8 ± 0.2 a
Co-cultures *
C. jejuni N16-1419 + L. reuteri PTA8_1 7.5 ± 0.4 A 8.5 ± 0.8 A 9.9 ± 0.2 a 10.2 ± 0.1 a
C. jejuni N16-1419 + L. reuteri PTA5_F13 BDL a 9.3 ± 0.1 b 6.3 ± 0.1 A 10.2 ± 0.1 B
Data presented as the mean and standard deviation of three biological replicates. Mean values with different alphabetical superscript letters are significantly different at p < 0.05.
* In co-cultures only C. jejuni cells were enumerated on selective plates (CampyFood ID Agar) and qPCR BDL, below the detection limit, with a limit of detection 1 log CFU/mL.
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3.3. Reuterin Produced by L. reuteri PTA5_F13 Kills C. jejuni N16-1419 during Co-Cultures
In a next step, we tested the effect of in situ produced reuterin on Campylobacter during co-cultures
of reuterin-producing L. reuteri PTA5_F13 and C. jejuni N16-1419 with and without glycerol.
We observed an increase of the 16S rRNA gene copy number indicating the growth of C. jejuni
N16-1419 when co-cultured with L. reuteri PTA8_1 in the presence or without glycerol (Table 3).
Similarly, there was no significant difference (p > 0.05) in the viable cell counts during incubation
with glycerol or without glycerol in the medium. Acetate and succinate were the main metabolites
produced, at similar levels to those found in C. jejuni N16-1419 mono-cultures. The final pH of the
co-cultures with L. reuteri PTA8_1 with or without glycerol was similar to the pH of the non-inoculated
CAMH media (Table 2).
During co-cultures with reuterin-producing L. reuteri PTA5_F13 in CAMH medium with 28 mM
glycerol, the viable cell counts of C. jejuni N16-1419 drastically decreased below the detection limit
(1 log CFU/mL) after 24 h incubation, while the number of 16S rRNA gene copies was reduced by
1.3 ± 0.4 log gene copies (Table 3). Succinate, a main metabolite of C. jejuni N16-1419, was low produced,
reaching final concentrations of 0.8 ± 0.1 mM compare with 5.3 ± 0.4 mM during mono-cultures.
Glycerol was consumed (25.4 ± 0.4 mM, 93%) and acrolein (0.1 ± 0.0 mM), 1,3-PDO (6.2 ± 0.6 mM) and
3-HP (4.9 ± 0.8 mM) were produced, and the pH dropped from 7.3 to 5.8 after 24 h of fermentation,
while 2.2 mM lactate was also produced (Table 2). In contrast, in the absence of glycerol, a significant
growth C. jejuni N16-1419 was observed during co-culture with L. reuteri PTA5_F13 (Table 3). This was
reflected by a higher metabolite production compared to co-cultures with glycerol, with a higher yield
of acetate (7.9 ± 0.5 mM) and succinate (5.7 ± 1.3 mM), while the pH was maintained at 7.3. Altogether,
these findings suggest that in the presence of 28 mM glycerol, L. reuteri PTA5_F13 synthesised reuterin
leading to the killing of C. jejuni.
4. Discussion
The need for novel strategies to reduce Campylobacter in poultry and poultry products becomes more
urgent [27]. Biosecurity and hygiene procedures that are implemented to prevent flock colonisation
by Campylobacter are limited due to uncontrolled environmental factors in organic flocks, and by
difficulties to strictly respect biosecurity rules in conventional flocks throughout the rearing stages [28].
Among alternative strategies to prevent Campylobacter occurrence in poultry and poultry products,
a particular attention has been shifted to biocontrol approaches, involving the use of naturally-produced
compounds and microbial competitive exclusion [29].
Reuterin is produced by certain strains of L. reuteri during anaerobic fermentation of glycerol and
has a broad-spectrum antimicrobial property against enteric pathogens and intestinal bacteria [21].
The combine antimicrobial effect of reuterin and nisin was investigated on a single strain of C. jejuni
in milk [30]. However, the authors did not provide information on the effective concentration of
reuterin, and more specifically on acrolein. Our work reports for the first time the sensitivity of a broad
panel of C. jejuni and C. coli isolates to reuterin and provides a first clear evidence of the killing of
C. jejuni. The chicken intestine is the main reservoir of Campylobacter contaminated meat and human
campylobacteriosis [31,32]. Therefore, our data also indicate high activity of reuterin on chicken
intestinal strains.
Campylobacter spp. exhibited higher sensitivity to reuterin than E. coli K12, which is often used for
its high susceptibility as an indicator strain for testing reuterin activity [21]. Recently, the antimicrobial
activity of reuterin was suggested to involve a reaction of the active compound, acrolein [10] with
thiol groups of glutathione or redox-active proteins with subsequent inhibition of redox-base defences
causing oxidative stress [12,33]. The addition of exogenous thiol groups was shown to suppress the
antimicrobial effect of reuterin [10]. Total intracellular thiol content in E. coli cells decreased to about
20% of initial levels after exposure to acrolein [34], and GSH-deficient E. coli mutants were significantly
more susceptible to acrolein when compared to a wild type strain [33,34]. Genome analysis of several
Campylobacter strains has suggested that this genus does not encode homologs of the glutathione
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biosynthesis proteins [35,36] and might, therefore, lack detoxifying capacity against redox modifying
compounds such as acrolein. This characteristic likely explains the high sensitivity of Campylobacter
spp. to reuterin.
The production of reuterin by L. reuteri is a strain-specific characteristic [37]. The ability
of chicken-derived reuterin-producing L. reuteri PTA5_F13 to synthesize reuterin, and inactivate
C.jejuni in co-culture was evaluated and compared with L. reuteri PTA8_1, which does not produce
reuterin [17]. The phenotypic similarity of L. reuteri PTA8_1 and L. reuteri PTA5_F13 was confirmed
during mono-cultures without glycerol where there were no significant difference in cell growth and
main metabolite (lactate and acetate) production. However, as expected, glycerol was not utilized by
L. reuteri PTA8_1 during mono- and co-cultures, which lead to no significant difference in the metabolite
profile in the presence or absence of glycerol and no reuterin formation. We confirmed reuterin
synthesis by chicken-derived L. reuteri PTA5_F13 with the formation of acrolein, 1,3-PDO and 3-HP in
conditions of the co-cultures, selected to promote the growth of Campylobacter spp. The intermediate
product of glycerol conversion 3-HPA was not detected, likely because it can be converted to 1,3-PDO
in the presence of glucose and also chemically reacts to acrolein at the cultivation conditions used
(Figure 1) [10].
Our results show that C. jejuni N16-1419 was killed during co-cultures with L. reuteri PTA5_F13 in
the presence of glycerol. In the absence of glycerol, no anti-Campylobacter activity was observed for
both reuterin-producing and non-reuterin producing L. reuteri strains. Kobierecka et al. [38] reported
that oral administration of L. reuteri did not significantly reduce the level of Campylobacter colonization
in chicken. It appears that L. reuteri PTA5_F13 adapts to the presence of C. jejuni N16-1419 in co-culture
by an increase in the production of lactate (2 mM) which significantly reduced the pH of the culture
medium to pH 5.8 when glycerol was present. Neal-McKinney et al. [39] showed that CAMH medium
with 10 mM lactate or pH 5.12 (by HCl) reduced the growth of C. jejuni by 1 log CFU/mL compared to
the untreated control. Also, previous in vitro studies have shown that mildly acidic conditions, such
pH 5.0 at 42 ◦C in semisolid Brucella agar [40] and pH 5.5 at 37 ◦C in biphasic CAMH medium [41]
do not affect the growth (plate count and OD600 measurement) of C. jejuni after 24 h. Therefore,
we assume that the observed drop of pH from 7.3 to 5.8 that occurred during the co-culture with
L. reuteri PTA5_F13 was not responsible for observed C. jejuni inactivation. Our results indicate that
reuterin production is the predominant mechanism of C. jejuni killing by L. reuteri in vitro.
5. Conclusions
We identified reuterin as a potent antimicrobial with high activity against a broad panel of C. jejuni
and C. coli isolates. We also showed that in the presence of glycerol, chicken-derived reuterin-producing
L. reuteri PTA5_F13 has antimicrobial activity against C. jejuni in vitro and reuterin production is
required for this phenotype. The strong anti-Campylobacter effect may have the potential for use for
enhancing the decontamination of slaughter-house equipment. Furthermore, a future direction of this
research will focus on confirming our in vitro findings in Campylobacter-positive chicken gut microbiota,
using both in vitro chicken cecum fermentation models and animal experiments.
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